Severe, persistent pain in the upper abdomen — often boring through to the back — with nausea and vomiting that will not stop. That is the pancreatitis pattern.
Stop and seek medical assessment. Persistent vomiting also dehydrates and strains the kidneys — sip fluids.
Unrelenting abdominal pain, repeated vomiting, or signs of dehydration → urgent care or ER. And tell any anaesthetist before surgery: these drugs slow stomach emptying and raise the risk of aspiration under anaesthesia.
Allergic reaction: hives, swelling of the lips, tongue or throat, wheezing or dizziness can escalate to anaphylaxis within minutes — call 911 immediately. Site infection: spreading redness, heat, swelling, pus or fever is not wait-and-see; an abscess or cellulitis can need drainage or IV antibiotics. Unverified product: grey-market vials are frequently mislabelled or contaminated, so a reaction may be to endotoxin or the wrong contents, not the named compound.
A different engineering solution to the same half-life problem. Rather than acylation and albumin binding, dulaglutide covalently fuses two GLP-1 analog molecules to an IgG4 Fc fragment. The resulting protein is far too large for renal clearance and is recycled by the neonatal Fc receptor, giving a weekly dosing interval. Receptor pharmacology is standard GLP-1.
The AWARD programme established glycaemic efficacy in type 2 diabetes, and REWIND reported cardiovascular outcome benefit in a population with a substantial primary-prevention component. A mature, well-evidenced agent.
FDA-approved for type 2 diabetes and cardiovascular risk reduction. Prescription-only. Not approved for weight management, unlike semaglutide and tirzepatide.
Boxed warning for rodent thyroid C-cell tumours; MTC/MEN2 contraindication. Gastrointestinal effects. Physician supervision required.
0.75 mg once weekly SC, up to a maximum of 4.5 mg, per the AWARD programme and FDA label.
Reported from clinical trials or FDA labelling as a matter of record. It is not a recommendation, and for unapproved compounds no dose has been shown safe or effective in humans.
Above is what was administered in trials or on FDA labels, reported as fact. We do not convert it into a personal protocol, calculate a dose for your body weight, or tell you what to inject or how to reconstitute it — that decision belongs with a licensed physician. See our editorial policy.
Regulatory status changes. This page reflects our reading of public sources as of July 2026 and should be independently verified before it is relied upon.